The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and ...
BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced Tuesday that the U.S. Food and Drug Administration has approved its epinephrine injection USP in both single-dose and ...
J.P. Morgan has upgraded Amneal Pharmaceuticals, Inc (NASDAQ:AMRX), noting the company’s generics business is increasingly well-positioned with a solid Crexont launch and continued momentum across the ...
A pharmaceutical corporation sued Colorado Friday in federal court aiming to bring a halt to a law approved in 2023, which the New Jersey-based company said makes it provide generic allergy pens to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results